Sponsor Pipeline

Xianmin Song, MD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT06468267
RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.		 overall status: Recruiting → Unknown
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06930105 Impact of Low-intensity Chemotherapy Combined With Short-course Blinatumomab on Allo-HSCT… Acute Lymphoid Leukemia (ALL) Not Yet Recruiting
Disease Areas
Leukemia (1) Acute Lymphoblastic Leukemia (ALL) (1)
Get alerts when Xianmin Song, MD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free